Biogen SG&A Expense (Annual) Analysis

Biogen Inc (BIIB)

217.81 -0.25 (-0.11%) USD | NASDAQ | May 24, 16:00

218.25 +0.44 (+0.20%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1984. Upgrade now.

Date	Value
December 31, 2023	2.550B
December 31, 2022	2.404B
December 31, 2021	2.674B
December 31, 2020	2.504B
December 31, 2019	2.375B
December 31, 2018	2.106B
December 31, 2017	1.934B
December 31, 2016	1.947B
December 31, 2015	2.113B
December 31, 2014	2.232B
December 31, 2013	1.712B
December 31, 2012	1.277B
December 31, 2011	1.056B
December 31, 2010	1.032B
December 31, 2009	1.127B
December 31, 2008	1.061B
December 31, 2007	776.10M
December 31, 2006	685.07M
December 31, 2005	644.76M
December 31, 2004	580.28M

Date	Value
December 31, 2003	174.60M
December 31, 2002	88.02M
December 31, 2001	231.05M
December 31, 2000	169.27M
December 31, 1999	146.03M
December 31, 1998	115.21M
December 31, 1997	90.10M
December 31, 1996	73.63M
December 31, 1995	40.29M
December 31, 1994	24.69M
December 31, 1993	102.50M
December 31, 1992	85.80M
December 31, 1991	14.30M
December 31, 1990	10.10M
December 31, 1989	9.00M
December 31, 1988	8.30M
December 31, 1987	8.00M
December 31, 1986	8.10M
December 31, 1985	39.00M
December 31, 1984	8.10M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

2.375B

Minimum

2019

2.674B

Maximum

2021

2.501B

Average

2.504B

Median

2020

SG&A Expense (Annual) Benchmarks